Akebia Therapeutics to Report Second Quarter Financial Results and Discuss Recent Business Highlights
Akebia to Host Conference Call on August 25th at 9:00 a.m. ET
CAMBRIDGE, Mass., Aug. 23, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the second quarter ended June 30, 2023 on Friday, August 25, 2023.
Akebia will host a conference call on Friday, August 25, 2023 at 9:00 a.m. ET to discuss its financial results and recent business highlights. To access the call by phone, please click on this Registration Link, and you will be provided with dial in details. To avoid delays, we encourage dialing into the conference call fifteen minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-second-quarter-financial-results-and-discuss-recent-business-highlights-301908497.html
SOURCE Akebia Therapeutics
